Description
GenX Pharma CJC DAC-1295 2 mg is a long-acting research peptide developed for scientists investigating the intricate mechanisms of growth hormone regulation and endocrine signaling. Engineered with a Drug Affinity Complex (DAC), this modified analogue of Growth Hormone Releasing Hormone (GHRH) is designed to exhibit prolonged biological activity, making it a preferred choice for laboratory studies requiring extended observation of peptide-receptor interactions and hormone signaling dynamics.
Unlike conventional GHRH analogues, CJC DAC-1295 is extensively researched for its sustained interaction with GHRH receptors, allowing scientists to examine long-duration endocrine responses, growth factor regulation, and peptide pharmacokinetics. Its unique molecular design has made it an important tool in modern peptide science, particularly in research focused on hormonal physiology, metabolic signaling, and growth factor biology.
Each package contains 5 lyophilized vials, with 2 mg of CJC DAC-1295 per vial, providing a consistent, high-purity formulation for advanced scientific investigations. Manufactured by GenX Pharma, every batch is produced under rigorous quality standards to ensure exceptional purity, stability, and reliability for professional laboratory use.
Key Features
- Long-acting CJC DAC-1295 (Drug Affinity Complex) research peptide
- 2 mg of high-purity peptide per vial
- 5 lyophilized vials per pack
- Modified GHRH analogue with extended biological activity
- Ideal for long-term endocrine and peptide signaling research
- Extensively studied in growth hormone and metabolic physiology
- High-purity laboratory-grade formulation
- Manufactured under strict quality control standards
- Intended exclusively for laboratory and scientific research applications
How It Works
CJC DAC-1295 is designed to mimic the activity of Growth Hormone Releasing Hormone (GHRH) while incorporating a Drug Affinity Complex (DAC) that significantly extends its biological lifespan. This prolonged activity enables researchers to evaluate sustained receptor engagement and investigate how continuous GHRH stimulation influences downstream signaling pathways over extended periods.
In laboratory research, CJC DAC-1295 is commonly utilized to study endocrine communication, IGF-1 regulation, peptide pharmacokinetics, and molecular pathways involved in growth hormone physiology. Its extended duration also makes it valuable for comparative studies examining the differences between long-acting and short-acting GHRH analogues, providing deeper insights into peptide behavior and receptor biology.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredient: CJC DAC-1295 (Drug Affinity Complex) – 2 mg
Packaging: 5 Lyophilized Vials
Reviews
There are no reviews yet.